Adjuvant Chemo Halves Recurrence Risk in Rare Kidney Cancer Adjuvant Chemo Halves Recurrence Risk in Rare Kidney Cancer
The risk of recurrence in a rare form of urothelial carcinoma is halved by adding chemotherapy to surgery, the results of a UK study reveal, although many questions remained to be answered.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Hematology | Kidney Cancer | Study | Urology & Nephrology